Back to Search Start Over

Ustekinumab bests etanercept in phase III study

Authors :
Jancin, Bruce
Source :
Skin & Allergy News. April, 2009, Vol. 40 Issue 4, p38, 1 p.
Publication Year :
2009

Abstract

SAN FRANCISCO -- Ustekinumab outperformed etanercept for treatment of psoriasis in the first-ever head-to-head comparison of the two biologic agents. The 12-week phase III multicenter trial involved 903 patients with [...]

Details

Language :
English
ISSN :
00376337
Volume :
40
Issue :
4
Database :
Gale General OneFile
Journal :
Skin & Allergy News
Publication Type :
Periodical
Accession number :
edsgcl.198472203